Laser Complications: Identification, Grading and Management Pathways (2026)
Complications from aesthetic energy devices are best managed through two axes: timing (immediate under 24 hours, early 24 hours to 4 weeks, delayed beyond 4 weeks) and severity (mild, moderate, severe). Most adverse events are predictable consequences of parameter selection, and the majority are preventable with test spots, conservative first-pass settings, adequate cooling and strict photoprotection. The single most common delayed complaint is post-inflammatory hyperpigmentation, which is far easier to prevent than to reverse.
A Two-Axis Classification
Classifying by timing tells you the likely mechanism; grading by severity tells you the urgency. Documenting both creates a defensible clinical record and a clear escalation path.
| Window | Typical events | Usual mechanism |
|---|---|---|
| Immediate (<24 h) | Erythema, oedema, pain, urticaria, immediate whitening | Expected thermal response; excessive fluence; cooling failure |
| Early (24 h – 4 weeks) | Blistering, crusting, erosions, infection, contact dermatitis, acneiform eruption | Epidermal injury, barrier failure, bacterial or herpetic infection |
| Delayed (>4 weeks) | PIH, hypopigmentation, persistent erythema, scarring, milia, textural change | Melanocyte overstimulation or destruction; prolonged inflammation; dermal injury |
Severity Grading and Escalation
| Grade | Presentation | Action |
|---|---|---|
| Mild | Transient erythema and oedema settling within 48–72 h | Cooling, emollient, photoprotection, reassurance; no intervention required |
| Moderate | Blistering or crusting limited to part of the field; focal PIH | Occlusive dressings, topical antimicrobial if needed, topical tyrosinase inhibitor; review within 72 h |
| Severe | Confluent blistering, spreading infection, ulceration, early atrophic change | Same-day review, systemic therapy as indicated, early dermatology referral, incident documentation |
Management by Event
Persistent Erythema
Erythema beyond the expected window suggests sustained inflammation. Reduce the topical load — stop actives, use a simple emollient, apply broad-spectrum photoprotection, and consider low-fluence vascular laser (PDL or long-pulsed 1064 nm) once the barrier has recovered. Persistent erythema after ablative resurfacing commonly lasts 4–12 weeks and is part of normal healing, not a complication, provided it is fading.
Blistering and Erosions
Blistering means the epidermal injury exceeded the intended depth. Management is supportive and infection-focused:
- Leave the blister roof intact where possible; it acts as a biological dressing.
- Occlusive or semi-occlusive dressing, changed aseptically.
- Topical antimicrobial for eroded areas; escalate to systemic therapy at signs of spreading infection.
- Consider herpes prophylaxis — many “infections” after resurfacing are herpetic reactivation, especially around the perioral area.
Post-Inflammatory Hyperpigmentation (PIH)
PIH is the most frequent delayed complaint and the most litigated. Prevention outperforms treatment:
- Prevent: test spots, conservative first treatment, adequate cooling, correct endpoint, rigorous photoprotection including visible light, priming in higher Fitzpatrick types.
- Treat: first-line is topical — tyrosinase inhibitors, azelaic acid, retinoids as tolerated, plus strict photoprotection. Most PIH resolves over 3–12 months without device intervention.
- Resist early retreatment. Re-lasing an inflamed, pigmented field is the most reliable way to convert a self-limiting PIH into persistent dermal pigmentation. Wait until the field is quiescent, generally at least 3 months, then use low-fluence settings.
Hypopigmentation
Hypopigmentation signals melanocyte loss rather than stimulation, and it is considerably harder to manage than PIH. It is most often seen after aggressive ablative resurfacing, excessive cryotherapy, or over-treatment with pigment-specific wavelengths. Management is largely expectant; some cases respond to narrowband UVB or excimer therapy under dermatology supervision, but permanent change is possible. Prevention — conservative parameters, correct endpoint — is the only reliable strategy.
Scarring
Atrophic or hypertrophic scarring after energy-device treatment is uncommon but consequential. Risk rises with excessive fluence, excessive density, pulse stacking, inadequate cooling, and treating over active infection. Early hypertrophic change responds to intralesional corticosteroid, silicone sheeting and vascular laser for erythema; established atrophy may require fractional resurfacing once mature — typically no earlier than 3–6 months.
Prevention System for Clinics
- Mandatory test spot at 2–4 weeks before full-field treatment in all Fitzpatrick III+ patients and before any ablative procedure.
- Parameter logging at every visit: fluence, spot, pulse, density, passes, cooling method, observed endpoint.
- Standardised photography — identical lighting, distance, angle, and background. This is your clinical and medico-legal record.
- Device-appropriate cooling verified before each session, not assumed.
- Written aftercare including photoprotection, what is normal, and explicit red-flag symptoms with a contact route.
- Incident register — every complication logged with root cause. Patterns only become visible in aggregate.
What to Tell Patients Before Treatment
Set out the expected normal course — erythema, oedema, and for ablative work, crusting — separately from the red flags: spreading pain, purulent discharge, fever, blistering beyond the treated pattern, or pigment change persisting beyond eight weeks. Patients who understand the difference present earlier and escalate appropriately, which measurably reduces severe outcomes.
Related reading
Frequently asked questions
How long does post-laser redness normally last?
After non-ablative treatment, erythema usually settles within 24–72 hours. After fractional or fully ablative resurfacing, erythema commonly persists 4–12 weeks and is part of normal healing provided it is steadily fading.
What is the most common complication after laser treatment?
Post-inflammatory hyperpigmentation is the most common delayed complication, particularly in Fitzpatrick III–VI and after ablative procedures. It is far easier to prevent with test spots and conservative settings than to reverse once established.
When can a laser be safely repeated after PIH?
Retreatment should wait until the treated field is completely quiescent, generally at least 3 months. Re-lasing inflamed, hyperpigmented skin is the most reliable way to convert self-limiting PIH into persistent dermal pigmentation.
How should post-laser blistering be managed?
Keep the blister roof intact as a biological dressing, apply occlusive or semi-occlusive dressings changed aseptically, use topical antimicrobials on eroded areas, and escalate to systemic therapy if infection spreads. Consider herpes prophylaxis, since many post-resurfacing infections are herpetic reactivation.
Is hypopigmentation reversible after laser?
Hypopigmentation indicates melanocyte loss and is harder to treat than hyperpigmentation. Some cases respond to narrowband UVB or excimer therapy under dermatology supervision, but permanent change is possible, making prevention through conservative parameters essential.
References
- Clinical Pathway Guideline for Prevention, Identification and Graded Management of Aesthetic Complications
- Expert Consensus on Management of Aesthetic Complications
- Guideline on Diagnosis and Treatment of Common Diseases in Laser Aesthetics
Need parameter charts for your clinic?
SMIO supplies device-specific clinical parameter sheets, training and calibration reports.
Last updated: 2026-09-05 ｜ SMIO Professional Aesthetic Devices
